(URGN) Urogen Pharma complete technical analysis [charts+indicators] | Buy/Sell Urogen Pharma | (URGN) share price targets
Complete technical analysis of Urogen Pharma (URGN) by charts plus indicators, forecast predictions and share price targets for Urogen Pharma (URGN)
Urogen Pharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-21 View latest technical analysis
10 day averaged volume of Urogen Pharma is 1087970
Date | Daily Closing Price | Open | High | Low | Volume |
21 Mon Oct 2024 | 12.52 | 12.79 | 12.82 | 12.42 | 0.499 times |
18 Fri Oct 2024 | 12.73 | 12.88 | 13.00 | 12.43 | 0.497 times |
17 Thu Oct 2024 | 12.84 | 12.79 | 13.12 | 12.22 | 0.655 times |
16 Wed Oct 2024 | 12.60 | 12.44 | 13.54 | 12.15 | 1.864 times |
15 Tue Oct 2024 | 12.26 | 12.21 | 12.31 | 11.84 | 0.712 times |
14 Mon Oct 2024 | 12.26 | 12.94 | 13.64 | 12.18 | 0.903 times |
11 Fri Oct 2024 | 12.60 | 11.82 | 12.63 | 11.58 | 0.676 times |
10 Thu Oct 2024 | 11.91 | 11.71 | 12.15 | 11.40 | 1.172 times |
09 Wed Oct 2024 | 11.89 | 13.00 | 13.00 | 11.30 | 2.192 times |
08 Tue Oct 2024 | 13.11 | 12.46 | 13.25 | 12.33 | 0.745 times |
My analysis of stock is bearish for shortterm, and stock might move down till 12.3 or till 11.9. Use a stoploss of 12.58 and if the stock hits stoploss, then it can shoot up till 12.9
Share price targets for Urogen Pharma (URGN)
Target Type | Value |
Downside Target | 11.30 |
Downside Target | 11.84 |
Downside Target | 12.22 |
Upside Target | 13.08 |
Upside Target | 13.64 |
Upside Target | 13.66 |
Upside Target | 13.69 |
Upside Target | 14.57 |
Upside Target | 14.89 |
Upside Target | 16.50 |
Upside Target | 18.15 |
Upside Target | 20.70 |
Intraday share price targets for Urogen Pharma (URGN)
Target Type | Value |
Downside Intraday Target | 12.35 |
Downside Intraday Target | 12.19 |
Upside Intraday Target | 12.75 |
Upside Intraday Target | 12.99 |
Upside Intraday Target | 12.59 |
Weekly technical analysis of Urogen Pharma (URGN)
Date | Weekly Closing Price | Open | High | Low | Volume |
21 Mon Oct 2024 | 12.52 | 12.79 | 12.82 | 12.42 | 0.108 times |
18 Fri Oct 2024 | 12.73 | 12.94 | 13.64 | 11.84 | 0.863 times |
11 Fri Oct 2024 | 12.60 | 12.71 | 13.25 | 11.30 | 3.048 times |
04 Fri Oct 2024 | 12.70 | 12.94 | 13.08 | 12.22 | 1.048 times |
27 Fri Sep 2024 | 12.90 | 13.55 | 13.66 | 12.61 | 0.406 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Urogen Pharma (URGN)
Date | Monthly Closing Price | Open | High | Low | Volume |
21 Mon Oct 2024 | 12.52 | 12.63 | 13.64 | 11.30 | 1.258 times |
30 Mon Sep 2024 | 12.70 | 13.83 | 14.57 | 12.60 | 0.896 times |
30 Fri Aug 2024 | 13.91 | 16.50 | 16.50 | 13.69 | 1.17 times |
31 Wed Jul 2024 | 16.45 | 16.92 | 18.15 | 14.89 | 0.353 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Urogen Pharma (URGN)
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Urogen Pharma ( (URGN) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Urogen Pharma stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Urogen Pharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Urogen Pharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Urogen Pharma in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Urogen Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 12.36 and Urogen Pharma (URGN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Urogen Pharma (URGN) stock. Volume based technical analysis of Urogen Pharma (URGN) stock is negative.
Urogen Pharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Urogen Pharma ( (URGN) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Urogen Pharma stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Urogen Pharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Urogen Pharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Urogen Pharma in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Urogen Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 12.36 and Urogen Pharma (URGN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Urogen Pharma (URGN) stock. Volume based technical analysis of Urogen Pharma (URGN) stock is negative.
Urogen Pharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.